DIA 2019 Global Annual Meeting

Innovation is a term that has been thrown around in Pharmacovigilance for years associated with a promise to change the entire PV paradigm, reduce costs, and optimize patient safety outcomes. No longer a distant concept, cognitive automation and a consolidated data repository are now strategic initiatives leveraged by firms globally. These advanced strategies could allow regulators and sponsors to leverage new tools to improve identification of important safety signals and generate more meaningful health care insights. So, what does this actually mean? What are the benefits? What are the risks? And where do we start? Hear from Deloitte as we provide a perspective on how patient safety is being reimagined through the cooperation and lessons learned of industry, regulators, investigators, HCPs, and patients.